Sage Journals: Discover world-class research

Abstract

There is increasing evidence that chronic obstructive pulmonary disease (COPD) is not simply a disease of old age that is largely restricted to heavy smokers, but may be associated with insults to the developing lung during foetal life and the first few years of postnatal life, when lung growth and development are rapid. A better understanding of the long-term effects of early life factors, such as intrauterine growth restriction, prenatal and postnatal exposure to tobacco smoke and other pollutants, preterm delivery and childhood respiratory illnesses, on the subsequent development of chronic respiratory disease is imperative if appropriate preventive and management strategies to reduce the burden of COPD are to be developed. The extent to which insults to the developing lung are associated with increased risk of COPD in later life depends on the underlying cause, timing and severity of such derangements. Suboptimal conditions in utero result in aberrations of lung development such that affected individuals are born with reduced lung function, which tends to remain diminished throughout life, thereby increasing the risk both of wheezing disorders during childhood and subsequent COPD in genetically susceptible individuals. If the current trend towards the ever-increasing incidence of COPD is to be reversed, it is essential to minimize risks to the developing lung by improvements in antenatal and neonatal care, and to reduce prenatal and postnatal exposures to environmental pollutants, including passive tobacco smoke. Furthermore, adult physicians need to recognize that lung disease is potentially associated with early life insults and provide better education regarding diet, exercise and avoidance of smoking to preserve precious reserves of lung function in susceptible adults. This review focuses on factors that adversely influence lung development in utero and during the first 5 years of life, thereby predisposing to subsequent COPD.

Keywords

adult foetal origins of lung disease foetal programming infant intrauterine growth restriction lung function lung growth and development pollution prematurity

Introduction

Chronic obstructive pulmonary disease (COPD) is a serious global health problem, which is increasing in prevalence worldwide, with serious social and economic burdens [GOLD, 2011]. The World Health Organization (WHO) estimates that around 210 million people worldwide have COPD [WHO, 2008]. COPD is the primary contributor to mortality caused by chronic lower respiratory diseases, which became the third leading cause of death in the USA in 2008 [CDC, 2012]. A chronic inflammatory response to inhaled smoke and other noxious particles results in pathological changes in susceptible subjects with subsequent air trapping, progressive airflow limitation and increasing breathlessness characteristic of COPD. A diminished ratio of forced expiratory volume in 1 s to forced vital capacity (FEV₁/FVC) has frequently been used in clinical practice and research to diagnose COPD, with severity based on the level of FEV₁. This can, however, lead to confusion and it is now recommended that the term ‘COPD’ only be used in the appropriate clinical (diagnostic) context [Agusti and Vestbo, 2011; GOLD, 2011; Postma et al. 2012].

Until recently, cigarette smoking was considered the main causal factor for developing COPD. However, evidence from population-based studies now suggests that both indoor and outdoor pollution and gene–environment interactions make a greater contribution to the burden of COPD than previously appreciated [Salvi and Barnes, 2009]. In addition, there has been growing awareness that the origins of many chronic adult lung diseases such as COPD may arise very early in life, that is, the ‘foetal origins’ hypothesis. The concept that chronic respiratory disease in adulthood is not simply due to an accelerated decline in lung function with ageing, but failure to achieve optimal peak function by early adulthood due to prior adverse exposures, was first proposed several decades ago. Subsequent studies showed that both low birth weight (LBW) and respiratory infections in infancy were associated with decreased adult lung function and death from COPD [Barker et al. 1991]. Evidence to support the concept of ‘foetal programming’, whereby insults during critical periods of development produce permanent structural, physiological or epigenetic changes with lifelong consequences [Miller and Marty, 2010; Barker, 2012], has also been provided by experimental animal models [Kallapur and Ikegami, 2006; Kramer et al. 2009; Shimoda and Semenza, 2011; Abbott and Winzer-Serhan, 2012; Hilgendorff et al. 2012; Magnani et al. 2012; Maritz and Mutemwa, 2012; Sutherland et al. 2012]. These studies have shown that insults to the developing lung during intrauterine or very early postnatal life lead to increased susceptibility to respiratory disease during both childhood and later life [Gluckman et al. 2008; Harding and Maritz, 2012].

Recent adaptations that enable spirometric measures of lung function to be applied from birth and throughout the preschool years [Stocks and Lum, 2012], and the incorporation of such tests into clinical and epidemiological studies commencing from birth have greatly enriched our understanding of the effects of prenatal insults and the early origins of adult lung disease. Subsequent follow up of these cohorts into adult life has also produced clear evidence of ‘tracking’, whereby an individual’s lung function remains on a similar centile over time. Thus, infants born with low lung function due to prenatal insults or those in whom normal lung and airway growth during the first years of life is impeded by postnatal insults, tend to retain this position thereafter [Bisgaard et al. 2012]. Since diminished lung function by early school age is a strong predictor of subsequent low lung function in early adulthood [Phelan et al. 2002; Sears et al. 2003; Stern et al. 2007], such individuals will be at increased risk of COPD [James et al. 2005].

This review will focus on factors that affect structural and functional maturation of the lung and the impact of alterations in early lung development (i.e. up to 5 years of age) on COPD. Due to the immense literature in this field, citations during the past decade have been prioritized, the bibliographies of which contain pertinent references to the older literature. Since the ultimate result of aberrant lung development depends on the type, severity and duration of the insult and the developmental stage at which it occurs [Kallapur and Ikegami, 2006], the review commences with a brief description of normal lung development.

Normal lung development

Lung development, which is influenced by numerous mechanical and biochemical factors, commences in utero and continues through various phases to adolescence and early adulthood [Quanjer et al. 2010, 2012], with the most marked structural changes occurring during foetal life and the first few years after birth [Burri, 2006]. In humans, the lung first appears during the fourth week of gestation and the two lungs can be distinguished as separate organs by 6 weeks. By 17 weeks’ gestation, all conducting airways have formed by branching morphogenesis [Morrisey and Hogan, 2010], with airway wall structure and epithelium being essentially in adult form by 24 weeks’ gestation. Mechanical forces, exerted on lung tissue through alterations in lung expansion, are a major determinant of foetal lung development [Hooper and Wallace, 2006]. Such forces are dependent on appropriate quantities of lung fluid and foetal breathing movements, which are detected from about 10 weeks’ gestation. Airway smooth muscle (present from 6 weeks’ gestation and innervated from 8 weeks’ gestation) is important for fluid movement within the lung. From 16 weeks’ to 27 weeks’ gestation there is growth and maturation of the peripheral airways to form prospective respiratory airways, differentiation of epithelial cells to form type I and type II alveolar cells and further development of the pulmonary capillary network. By this stage, the blood–gas barrier is as thin as in the adult and of sufficient surface area to sustain life. Alveoli appear from 29 weeks’ gestation by a process of alveologenesis [Galambos and Demello, 2008], which depends on the presence of elastin, smooth muscle cells and a capillary network [Burri, 2006], with 100–150 million alveoli present by 40 weeks’ gestation, that is, ‘full-term’ [Stocks and Hislop, 2002]. While some structural studies have suggested that the variable adult number of alveoli (300–600 million) is reached by 2–4 years, there is no certainty about when alveoli finally cease to multiply. Recent studies using helium³ magnetic resonance imaging in man [Butler et al. 2012; Narayanan et al. 2012], as well as experimental animal studies [Schittny et al. 2008], suggest that alveoli may continue to increase in number as well as in size and complexity through to adolescence and even adulthood. While this offers exciting possibilities with respect to recovery from earlier injuries, it also widens the potential window of vulnerability of the developing lung, with respect to environmental exposures [ATS, 2004]. Alveoli continue to increase in size and complexity to increase the gas-exchanging surface area until body growth is complete.

After birth, lung size increases with body size, but is also influenced by age, sex and ethnicity [Quanjer et al. 2010, 2012]. Maximum lung volumes are attained at around 22 years in males and slightly earlier in females [Kohansal et al. 2009; Quanjer et al. 2012], representing a 30-fold increase in lung volume and a 20-fold increase in gas-exchanging surface area between birth and maturity, with at least a doubling of airway length and diameter over the same period. Even in health, both FEV₁ and FVC gradually decline after reaching their peak in early adulthood, due to a gradual loss of lung elasticity [Quanjer et al. 2012]. Changes in FEV₁/FVC occur with age, being highest in early childhood when the airways are relatively large in relation to lung volume and elastic lung recoil is high [Quanjer et al. 2010]. Consequently, the use of fixed thresholds, such as < 0.7 for FEV₁/FVC, to diagnose airway obstruction should be avoided as it results in serious underdiagnosis in younger subjects and overdiagnosis in the elderly [Quanjer et al. 2011, 2012; Brusasco, 2012].

Early life influences that may predispose to COPD

The extent to which insults to the developing lung are associated with subsequent increased risk of COPD depends on the underlying cause, timing and severity of such derangements. For clarity, various risk factors are discussed individually below, but in reality it is the interaction between such factors in genetically susceptible individuals that will be important in predisposing to COPD. Whereas prenatal factors are more likely to impair airway development, postnatal factors tend to impact on subsequent airway growth, as well as alveolarization and microvasculature. Diminished airway calibre associated with suboptimal intrauterine conditions may be evident shortly after birth and prior to any postnatal insults. Reduced airway calibre and hence airflow limitation may reflect structural changes to the airway wall and supporting parenchyma as well as bronchial hyperresponsiveness (BHR). The complex relationship between deficits in airway function and BHR in early life, genetic susceptibility and subsequent respiratory morbidity and lung function has been highlighted by longitudinal cohort studies [Turner et al. 2004; Le Souef, 2005; Bisgaard et al. 2012].

Prenatal risk factors for COPD

Irregularities during the susceptible period of foetal lung development may render the adult lung less effective as a gas-exchanging unit and/or increase susceptibility to disease and the effects of ageing [Hooper and Wallace, 2006; Kallapur and Ikegami, 2006; Miller and Marty, 2010; Thornburg et al. 2010; Joss-Moore et al. 2011]. Differences in alveolar number due to early insults can influence the rate of disease progression, including accelerating rate of decline in FEV₁ in patients with COPD [Massaro and Massaro, 2004].

Maternal smoking during pregnancy

While the incidence of maternal smoking during pregnancy has decreased during the past decade, it remains the single, most important, potentially preventable insult to the developing lung and a major cause of sudden infant death, LBW, preterm delivery and intrauterine growth restriction (IUGR) [Hayatbakhsh et al. 2009]. Experimental studies in various animal models have demonstrated that in utero exposure to nicotine leads to smaller lungs with a reduced number of enlarged alveoli, alveolar changes suggestive of premature ageing and a low capillary density [Harding and Maritz, 2012]. There is evidence from animal models that prenatal exposure to nicotine causes abnormalities in airway branching and dimensions and results in increased airway smooth muscle and collagen deposition, with subsequent reductions in airflow limitation, reduced FEV₁ and airway hyperreactivity [Sandberg et al. 2011; Wongtrakool et al. 2012].

Most evidence regarding postnatal effects of intrauterine smoke exposure in humans on subsequent lung function or respiratory morbidity has been derived from epidemiological and physiological studies [Stocks and Dezateux, 2003; Svanes et al. 2004; Moshammer et al. 2006; Palmer et al. 2006; Goksor et al. 2007; Haberg et al. 2007; Wang et al. 2008; Hayatbakhsh et al. 2009; Wenten et al. 2009; Henderson et al. 2010; Hersoug et al. 2010; Schultz et al. 2010; Abbott and Winzer-Serhan, 2012; Neuman et al. 2012]. Prenatal nicotine exposure may predispose to BHR during infancy, especially in those with a maternal history of asthma, with BHR still evident in early adulthood [Goksor et al. 2007]. Prenatal nicotine exposure is also associated with poor lung function at birth, which persists into early adulthood [Svanes et al. 2004; Hayatbakhsh et al. 2009], regardless of postnatal exposure. Maternal smoking of 10 cigarettes/day was found to increase risk of COPD in offspring by 1.7 (95% confidence interval, 1.2–2.5) after adjustment for potential confounders. Within families, the effect of maternal smoking of 10 cigarettes/day had the same effect on airflow limitation in the offspring as 10 years of personal smoking by the offspring [Upton et al. 2004].

Low Birth Weight (LBW)

Most epidemiological studies have shown that LBW is associated with increased cardiovascular and respiratory morbidity in later life. Factors responsible for LBW include both preterm delivery and IUGR. The commonest causes of IUGR, usually defined as birth weight less than tenth centile for gestational age, are impaired transplacental supplies of oxygen and/or nutrients to the foetus, which are often associated with maternal smoking or pregnancy-induced hypertension [Pike et al. 2012; Narang and Bush, 2012]. Reductions in nutrients and oxygen supplies have wide-ranging effects on the developing lung, including diminished alveolar surface area, thickened air–blood barriers and a reduction in lung weight. Animal models have indicated that these changes persist into adulthood [Karadag et al. 2009; Pike et al. 2012].

IUGR has been identified as a risk factor for reduced lung function and respiratory morbidity during infancy [Hoo et al. 2004], childhood [Kotecha et al. 2010], and adulthood [Barker et al. 1991; Lawlor et al. 2005; Rona et al. 2005; Canoy et al. 2007], and has been shown to exacerbate the adverse impact of preterm delivery and postnatal hyperoxia. IUGR in the first and second trimester has been found to be associated with reduced vitamin E and abnormal lung function at 5 years of age, together with increased risk of developing asthma [Turner et al. 2011]. The long-term impact of poor maternal nutrition during pregnancy in humans has also been shown by the increased prevalence of COPD amongst those born to mothers exposed to the Dutch famine (1944–1945) [Lopuhaa et al. 2000].

Associations have been reported between maternal (prenatal) and postnatal dietary intake of fruit, fish or antioxidant vitamins and asthma [Fogarty and Britton, 2000], or COPD [Tabak et al. 2001]. Antioxidant vitamins may protect the lungs from oxidative damage by smoking or air pollution as shown in animal studies [Maritz and Rayise, 2011; Maritz et al. 2011]. Vitamin D is known to regulate multiplication of bronchial smooth muscle cells, which may be important in both asthma and COPD [Banerjee and Panettieri, 2012]. Recent studies have attempted to determine whether maternal vitamin D supplementation can prevent the occurrence of chronic respiratory diseases [Weiss and Litonjua, 2011]. A number of studies have shown that maternal diets poor in vitamin D may lead to an increased risk of reactive airways in the offspring [Devereux et al. 2007; Erkkola et al. 2009; Miyake et al. 2010; Camargo et al. 2011]. However, other studies have reported that higher serum 25(OH)D concentrations during pregnancy may increase the risk of asthma in offspring by 9 years of age [Gale et al. 2008], and that children receiving supplemental vitamin D in the first year of life have a nonsignificant increased risk of developing asthma [Hypponen et al. 2004]. Current evidence does not support routine vitamin D supplementation during pregnancy.

Postnatal risk factors for COPD

Chronic lung disease of prematurity

Advances in prenatal and neonatal intensive care have led to marked improvements in survival rates for extremely preterm infants during recent years, but the prevalence of pulmonary sequelae in such infants has not declined [Moore et al. 2012; Costeloe et al. 2012]. Preterm delivery, that is, that occurring before 37 weeks’ gestation, is the most common cause of abnormal lung development, and one with potentially life-long consequences. Although there are currently limited longitudinal studies beyond early adulthood, there is concern that such individuals face increased risk of developing COPD in later life [Silverman and Kuehni, 2007; Bush, 2008].

Infants born before 28 weeks’ gestation rarely survive without supplementary oxygen and ventilatory assistance, the iatrogenic effects of which may compound the disruption of lung development caused by preterm delivery per se. Exposure to hyperoxia, especially if combined with prenatal inflammation, results in the disruption of alveolar development, reduced surface area for gas exchange, diffuse fibrosis and increased airway resistance in mice [Velten et al. 2010]. Even if preterm infants can be managed in room air at birth, this is relatively hyperoxic compared with the foetal environment. Similarly, the switch from foetal to extrauterine breathing movements represents major changes in the mechanical forces imposed on the immature lung, which may adversely impact alveolar multiplication [Hooper and Wallace, 2006], elastin deposition and airway smooth muscle [Stocks and Hislop, 2002]. It is therefore hardly surprising that abnormal postnatal lung function and development have been reported even among preterm infants who require no ventilatory assistance at birth [Hoo et al. 2002; Friedrich et al. 2007; Colin et al. 2010].

Bronchopulmonary dysplasia (BPD) is commonly defined as continuing dependence on supplemental oxygen at 36 weeks’ gestation in those born prematurely. BPD develops as the net result of pulmonary inflammation, oxidant stress and mechanical trauma to these extremely fragile and immature lungs, leading to disruption of normal alveolar and vascular development. Morphological studies in infants who died with BPD have reported substantial thickening of airway wall dimensions over the entire size range of airways, compatible with subsequent airflow obstruction in survivors [Tiddens et al. 2008]. Animal models suggest that hyperoxic insults to the immature lung may not only result in smooth muscle hyperplasia and airway remodelling [Choi et al. 2009], but reprogramming of key innate immunoregulatory pathways in the lung [O’Reilly et al. 2008], thereby contributing to both reduced resistance to respiratory viral infections and the long-term risk of COPD.

In addition to increased risk of asthma and other respiratory morbidity, most longitudinal studies of lung function have reported evidence of persistent airflow limitation (reduced FEV₁ and FEV₁/FVC) and/or BHR during childhood, adolescence and adulthood in survivors of preterm birth [Vrijlandt et al. 2006; Baraldi and Filippone, 2007; Baraldi et al. 2009; Doyle and Anderson, 2010; Fawke et al. 2010; Kwinta and Pietrzyk, 2010; Greenough, 2012; Hacking et al. 2012; Kotecha et al. 2012a, 2012b]. However, the male disadvantage with respect to reduced lung function and increased morbidity that is evident during infancy and childhood [Becklake and Kauffmann, 1999], appears to be reversed in adulthood [Vrijlandt et al. 2005; Postma, 2007]. Evidence of persistent respiratory symptoms and abnormal structure and lung function has been reported in young adults with BPD [Wong et al. 2008]. The persistent reduction in airway function in those born preterm may be accompanied by an accelerated rate of decline of lung function [Doyle et al. 2006; Filippone et al. 2009]. Recent studies on young adult survivors of preterm birth have also revealed a worryingly high prevalence of current smoking (about 30% across various studies) [Doyle et al. 2006; Vrijlandt et al. 2006], which appears to further accelerate decline in lung function in this vulnerable population. Together, these findings suggest that young adult survivors of BPD may be left with residual functional and characteristic structural pulmonary abnormalities, most notably emphysema.

Postnatal growth and nutrition

As alveolar numbers continue to increase after birth, postnatal nutrition and growth also affect the size of the adult lung. Studies show that children who are breastfed have improved lung volumes relative to those who are formula fed in early life [Ogbuanu et al. 2009; Dogaru et al. 2012; Soto-Ramirez et al. 2012]. The impact of postnatal nutrition on lung development is especially pertinent in preterm infants, in whom nutrition and growth are often impaired, contributing to reduced lung function and increased risk of respiratory morbidity in survivors during childhood and adolescence [Pike et al. 2012]. Vitamin A, D or E deficiency seems to have greatest effect on alveolar rather than airway development, with evidence that postnatal supplementation may potentially improve lung structure both in animal studies and humans [Checkley et al. 2010; Zosky et al. 2011; Esteban-Pretel et al. 2013]. While evidence from observational studies suggests a role for diet in asthma and COPD, causality of the association is far less conclusive.

Postnatal exposure to environmental tobacco smoke

There are recognized difficulties in separating the effects of pre- and postnatal tobacco smoke exposure, since virtually all women who smoke during pregnancy continue to do so after child birth [Le Souef, 2000; Stocks and Dezateux, 2003]. Although current evidence suggests that smoking during pregnancy has the most detrimental effects on the developing lung, postnatal nicotine exposure has been shown to increase the risk of lower respiratory illness and reduced lung function in young children. Nevertheless, not all children who are exposed to pre- or postnatal tobacco smoke have diminished lung function or increased respiratory morbidity, reflecting, at least in part, differences in maternal and foetal genetic susceptibility [Tsai et al. 2008]. Several, though not all, studies have reported a protective effect of the infant and/or maternal GSTT₁ nonnull genotype in children of smoking mothers, with respect to lung function, airway reactivity and respiratory morbidity [Gilliland et al. 2002; Murdzoska et al. 2010; Schultz et al. 2010].

Environmental pollution

The developing lung is highly susceptible to damage from exposure to environmental pollutants [Miller and Marty, 2010; Soto-Martinez and Sly, 2010]. The association between acute and chronic exposure to environmental pollutants and respiratory symptoms [Dales et al. 2009; da Silva et al. 2012], as well as reduced lung function [Gauderman et al. 2007; Schindler et al. 2009; da Silva et al. 2012], is well described in both children and adults. However, during the last decade, there has been growing interest in determining the impact of early life exposures to specific environmental risk factors on the developing respiratory system. In addition to tobacco smoke, environmental pollutants relevant to respiratory tract illnesses include oxidant gases (ozone, nitrogen dioxide and oxygen), traffic-related emissions (carbon monoxide, nitrogen oxides and particulate matter [PM]), PM from biomass fuel combustion (wood, dung or straw) and xenobiotics. Recent WHO reports estimate that up to 35% of those with COPD in low- and middle-income countries developed the disease after exposure to biomass fuel combustion [Lopez et al. 2006]. School children in rural India, where use of biomass is common, also have significant reductions in lung function and increased incidence of asthma when compared with nonexposed peers [Padhi and Padhy, 2008].

Ambient ozone is formed by the action of sunlight on nitrogen oxides and reactive hydrocarbons, both of which are emitted by motor vehicles and industrial sources. Studies have demonstrated that foetal exposure to PM, ozone and carbon monoxide can lead to a host of developmental conditions including IUGR, LBW and preterm birth, with subsequent increased respiratory morbidity. Exposure to traffic-related air pollution during infancy affects lung function in children up to 8 years of age, particularly in those sensitized to common inhalant or food allergens [Schultz et al. 2012]. A direct link between childhood exposure to PM and increased vulnerability to adult respiratory disease is provided by studies showing an association between life-long biomass smoke exposure and development of COPD in noncigarette-smoking women [Grigg, 2009]. Experimental studies show that mice exposed to traffic-related PM, either pre- or postnatal, develop significant alterations of alveolar structure and lung elastic properties that adversely impact lung growth [Mauad et al. 2008]. Results from animal studies also implicate a number of xenobiotics (e.g. nitrofen, naphthalenes, arsenic, tetrachlorodibenzo-p-dioxin, di(2-ethylhexyl) phthalate) in adversely influencing lung maturation and growth [Miller and Marty, 2010].

Childhood respiratory illnesses

The association between respiratory infections during childhood and chronic lung disease in later life has long been recognized. However, whether this is due to a viral infection in early life that affects the normal course of lung development making the individual susceptible to airway obstruction thereafter, or to pre- or perinatal insults to the developing lung that predispose the infant to early wheeze and subsequent airway obstruction has remained the subject of much debate. Until recently, inability to measure routinely lung function in children below 6 years of age made it impossible to determine whether diminished lung function preceded early respiratory infections or vice versa, a situation that has now been overcome by advances in the field of infant and preschool lung function testing [Stocks and Lum, 2012]. While it has been reported that lower respiratory tract infections, especially those associated with respiratory syncytial virus (RSV), are associated with abnormal lung function at follow up [Broughton et al. 2007], several studies have shown that children hospitalized as a result of RSV tend to have abnormal lung function before as well as after such infections [Turner et al. 2002; Drysdale et al. 2011]. Considerable evidence now exists that diminished airway function, associated with a suboptimal intrauterine environment (e.g. maternal smoking, IUGR) may be present from birth and that such children are more likely to wheeze with subsequent viral infections [Pike et al. 2011, 2012; Narang and Bush, 2012]. In the follow up of the Tucson study at 22 years of age, those in the lowest quartile for forced expiratory flows during the first year of life prior to any infections had the lowest lung function as adults [Stern et al. 2007].

Although lung function was not measured in the Dunedin cohort until school age, subsequent assessments demonstrated that lung function tracked between 9 years of age and 26 years of age, the lowest FEV₁/FVC being observed in those with history of wheeze or asthma. Similarly, tracking of lung function has been clearly demonstrated in the Melbourne asthma cohort, with lower levels by 7 years of age in those with asthma (many of whom subsequently developed COPD) [Phelan et al. 2002; Tai et al. 2010]. A recent study suggested that childhood disadvantages, which included the additive effect of maternal, paternal or childhood asthma, maternal history of smoking and childhood respiratory infections, were at least as great a risk for subsequent COPD as those related to active smoking in adults [Svanes et al. 2010]. It has also been suggested that diagnosis of asthma as a child may confer a similar risk of developing COPD as an increase in age of 22 years or 62 pack years of cigarette smoking [Shirtcliffe et al. 2012]. This functional evidence, combined with the structural changes observed in animal models described above, suggest that airway abnormalities are determined during foetal or early postnatal life and will increase the risk both of developing wheezing illnesses during childhood and COPD in later life.

Summary

Normal lung development is essential to attain maximum lung health in adulthood and minimize the risk of COPD. A better understanding of the long-term effects of early life factors on subsequent development of respiratory disease is imperative if appropriate preventive and management strategies to reduce the burden of COPD are to be developed. Research in this field, however, is challenged by the need to separate the independent effects of genetic predisposition, preterm delivery, IUGR, neonatal respiratory disorders and the impact of a wide range of treatment strategies and early environmental insults, including childhood respiratory infections and environmental exposures. Adult chest physicians need to recognize the potential relevance of young adults presenting with airway obstruction and enquire about neonatal history including birth weight and preterm delivery. Investigations should then be directed at establishing the nature of the impairment and whether the airway obstruction is reversible in nature. It should be remembered that while reductions in airway calibre or increased airway wall compliance are usually responsible for symptoms of airway obstruction, reduced pulmonary elastic recoil, such as may result from a disruption of alveolar development in early life, can also contribute to decreased airflows and hence the risk of developing emphysematous changes and COPD.

The onset of well-recognized but benign age-related changes in lung function during early adulthood is of little consequence in health, due to the considerable lung reserves that are available. The outlook, however, is very different for those who fail to reach their full potential due to derangements in lung development or those in whom the rate of lung decline is accelerated due to active smoking/environmental exposures or to structural and functional alterations present since birth. In such individuals, symptoms of COPD and associated restrictions on lifestyle are likely to develop once a critical threshold of lung function is reached. Since a reduced FEV₁ in adult life carries with it a poor prognosis with respect not only to respiratory health but also to cardiovascular disease and overall mortality [Sin et al. 2005; Young et al. 2007], adult physicians need to recognize that lung disease is potentially associated with prematurity and other early life insults and offer long-term monitoring and advice to susceptible adults regarding the preservation of existing lung reserves. Where appropriate, such advice should include education regarding smoking cessation, physical activity levels and maintaining a healthy diet [GOLD, 2011].

Conclusion

Given the evidence presented above it is no longer plausible to consider COPD as a disease of old age that is largely restricted to heavy smokers. Instead it has been shown that antenatal programming, intra- and extrauterine environmental exposures and gene–environment interactions all play a major role in determining subsequent susceptibility to diseases such as COPD. As a result of such insults, some individuals are born with low lung function, which then tracks through life, those with the lowest lung function as infants and young children tending to retain this state thereafter. With increasing survival of ever more immature infants, an increasing proportion of the population may be at risk of COPD in the future. If the continuing increase in incidence of COPD is to be reversed, it is essential to not only provide better education regarding diet, exercise and avoidance of smoking to preserve precious reserves of lung function, but to minimize risks to the developing lung by improvements in antenatal and neonatal care and reduction in pre- and postnatal exposures to environmental pollutants.

Footnotes

Funding

This article received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Conflict of interest statement

The authors declare no conflicts of interest in preparing this article.

References

Abbott

Winzer-Serhan

(2012) Smoking during pregnancy: lessons learned from epidemiological studies and experimental studies using animal models. Crit Rev Toxicol 42: 279–303.

Agusti

Vestbo

(2011) Current controversies and future perspectives in COPD. Am J Respir Crit Care Med 184: 507–513.

ATS (2004) Consensus statement. Mechanisms and limits of induced postnatal lung growth. Am J Respir Crit Care Med 170: 319–343.

Banerjee

Panettieri

Jr (2012) Vitamin D modulates airway smooth muscle function in COPD. Curr Opin Pharmacol 12: 266–274.

Baraldi

Carraro

Filippone

(2009) Bronchopulmonary dysplasia: definitions and long-term respiratory outcome. Early Hum Dev 85: S1–S3.

Baraldi

Filippone

(2007) Chronic lung disease after premature birth. N Engl J Med 357: 1946–1955.

Barker

(2012) Sir Richard Doll Lecture. Developmental origins of chronic disease. Public Health 126: 185–189.

Barker

Godfrey

Fall

Osmond

Winter

Shaheen

(1991) Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ 303: 671–675.

Becklake

Kauffmann

(1999) Gender differences in airway behaviour over the human life span. Thorax 54: 1119–1138.

10.

Bisgaard

Jensen

Bonnelykke

(2012) Interaction between asthma and lung function growth in early life. Am J Respir Crit Care Med 185: 1183–1189.

11.

Broughton

Sylvester

Fox

Zuckerman

Smith

Milner

. (2007) Lung function in prematurely born infants after viral lower respiratory tract infections. Pediatr Infect Dis J 26: 1019–1024.

12.

Brusasco

(2012) Spirometric definition of COPD: exercise in futility or factual debate? Thorax 67: 569–570.

13.

Burri

(2006) Structural aspects of postnatal lung development – alveolar formation and growth. Biol Neonate 89: 313–322.

14.

Bush

(2008) COPD: a pediatric disease. COPD 5: 53–67.

15.

Butler

Loring

Patz

Tsuda

Yablonskiy

Mentzer

(2012) Evidence for adult lung growth in humans. N Engl J Med 367: 244–247.

16.

Camargo

Jr Ingham

Wickens

Thadhani

Silvers

Epton

. (2011) Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Pediatrics 127: e180–e187.

17.

Canoy

Pekkanen

Elliott

Pouta

Laitinen

Hartikainen

. (2007) Early growth and adult respiratory function in men and women followed from the fetal period to adulthood. Thorax 62: 396–402.

18.

CDC (2012) Chronic obstructive pulmonary disease among adults – United States, 2011. MMWR Morb Mortal Wkly Rep 61: 938–943.

19.

Checkley

West

Jr Wise

Baldwin

LeClerq

. (2010) Maternal vitamin A supplementation and lung function in offspring. N Engl J Med 362: 1784–1794.

20.

Choi

Kim

Hong

Kim

Choi

(2009) Bronchopulmonary dysplasia in a rat model induced by intra-amniotic inflammation and postnatal hyperoxia: morphometric aspects. Pediatr Res 65: 323–327.

21.

Colin

McEvoy

Castile

(2010) Respiratory morbidity and lung function in preterm infants of 32 to 36 weeks’ gestational age. Pediatrics 126: 115–128.

22.

Costeloe

Hennessy

Haider

Stacey

Marlow

Draper

(2012) Short term outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the EPICure studies). BMJ 345: e7976.

23.

Dales

Wheeler

Mahmud

Frescura

Liu

(2009) The influence of neighborhood roadways on respiratory symptoms among elementary schoolchildren. J Occup Environ Med 51: 654–660.

24.

da Silva

Saldiva

Dolhnikoff

(2012) Impaired lung function in individuals chronically exposed to biomass combustion. Environ Res 112: 111–117.

25.

Devereux

Litonjua

Turner

Craig

McNeill

Martindale

. (2007) Maternal vitamin D intake during pregnancy and early childhood wheezing. Am J Clin Nutr 85: 853–859.

26.

Dogaru

Strippoli

Spycher

Frey

Beardsmore

Silverman

. (2012) Breastfeeding and lung function at school age: does maternal asthma modify the effect? Am J Respir Crit Care Med 185: 874–880.

27.

Doyle

Anderson

(2010) Adult outcome of extremely preterm infants. Pediatrics 126: 342–351.

28.

Doyle

Faber

Callanan

Freezer

Ford

Davis

(2006) Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence. Pediatrics 118: 108–113.

29.

Drysdale

Wilson

Alcazar

Broughton

Zuckerman

Smith

. (2011) Lung function prior to viral lower respiratory tract infections in prematurely born infants. Thorax 66: 468–473.

30.

Erkkola

Kaila

Nwaru

Kronberg-Kippila

Ahonen

Nevalainen

. (2009) Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin Exp Allergy 39: 875–882.

31.

Esteban-Pretel

Marin

Renau-Piqueras

Sado

Barber

Timoneda

(2013) Vitamin A deficiency disturbs collagen IV and laminin composition and decreases matrix metalloproteinase concentrations in rat lung. Partial reversibility by retinoic acid. J Nutr Biochem 24: 137–145.

32.

Fawke

Lum

Kirkby

Hennessy

Marlow

Rowell

. (2010) Lung function and respiratory symptoms at 11 years in extremely preterm children: the EPICure Study. Am J Respir Crit Care Med 182: 237–245.

33.

Filippone

Bonetto

Cherubin

Carraro

Baraldi

(2009) Childhood course of lung function in survivors of bronchopulmonary dysplasia. JAMA 302: 1418–1420.

34.

Fogarty

Britton

(2000) The role of diet in the aetiology of asthma. Clin Exp Allergy 30: 615–627.

35.

Friedrich

Pitrez

Stein

Goldani

Tepper

Jones

(2007) Growth rate of lung function in healthy preterm infants. Am J Respir Crit Care Med 176: 1269–1273.

36.

Galambos

Demello

(2008) Regulation of alveologenesis: clinical implications of impaired growth. Pathology 40: 124–140.

37.

Gale

Robinson

Harvey

Javaid

Jiang

Martyn

. (2008) Maternal vitamin D status during pregnancy and child outcomes. Eur J Clin Nutr 62: 68–77.

38.

Gauderman

Vora

McConnell

Berhane

Gilliland

Thomas

. (2007) Effect of exposure to traffic on lung development from 10 to 18 years of age: a cohort study. Lancet 369: 571–577.

39.

Gilliland

Dubeau

Berhane

Avol

McConnell

. (2002) Effects of glutathione S-transferase M1, maternal smoking during pregnancy, and environmental tobacco smoke on asthma and wheezing in children. Am J Respir Crit Care Med 166: 457–463.

40.

Gluckman

Hanson

Cooper

Thornburg

(2008) Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 359: 61–73.

41.

Goksor

Amark

Alm

Gustafsson

Wennergren

(2007) The impact of pre- and post-natal smoke exposure on future asthma and bronchial hyper-responsiveness. Acta Paediatr 96: 1030–1035.

42.

GOLD (2011) Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease. [http://www.goldcopd.org]

43.

Greenough

(2012) Long term respiratory outcomes of very premature birth (< 32 weeks). Semin Fetal Neonatal Med 17: 73–76.

44.

Grigg

(2009) Particulate matter exposure in children: relevance to chronic obstructive pulmonary disease. Proc Am Thorac Soc 6: 564–569.

45.

Haberg

Stigum

Nystad

Nafstad

(2007) Effects of pre- and postnatal exposure to parental smoking on early childhood respiratory health. Am J Epidemiol 166: 679–686.

46.

Hacking

Gibson

Robertson

Doyle

(2012) Respiratory function at age 8–9 after extremely low birthweight or preterm birth in Victoria in 1997. Pediatr Pulmonol. [Epub ahead of print]

47.

Harding

Maritz

(2012) Maternal and fetal origins of lung disease in adulthood. Semin Fetal Neonatal Med 17: 67–72.

48.

Hayatbakhsh

Sadasivam

Mamun

Najman

Williams

O’Callaghan

(2009) Maternal smoking during and after pregnancy and lung function in early adulthood: a prospective study. Thorax 64: 810–814.

49.

Henderson

Newson

Rose-Zerilli

Ring

Holloway

Shaheen

(2010) Maternal Nrf2 and gluthathione-S-transferase polymorphisms do not modify associations of prenatal tobacco smoke exposure with asthma and lung function in school-aged children. Thorax 65: 897–902.

50.

Hersoug

Husemoen

Sigsgaard

Madsen

Linneberg

(2010) Indoor exposure to environmental cigarette smoke, but not other inhaled particulates associates with respiratory symptoms and diminished lung function in adults. Respirology 15: 993–1000.

51.

Hilgendorff

Parai

Ertsey

Juliana Rey-Parra

Thebaud

Tamosiuniene

. (2012) Neonatal mice genetically modified to express the elastase inhibitor elafin are protected against the adverse effects of mechanical ventilation on lung growth. Am J Physiol Lung Cell Mol Physiol 303: L215–L227.

52.

Hoo

Dezateux

Henschen

Costeloe

Stocks

(2002) The development of airway function in infancy following preterm delivery. J Pediatr 141: 652–658.

53.

Hoo

Stocks

Lum

Wade

Castle

Costeloe

. (2004) Development of lung function in early life: influence of birth weight in infants of nonsmokers. Am J Respir Crit Care Med 170: 527–533.

54.

Hooper

Wallace

(2006) Role of the physicochemical environment in lung development. Clin Exp Pharmacol Physiol 33: 273–279.

55.

Hypponen

Sovio

Wjst

Patel

Pekkanen

Hartikainen

. (2004) Infant vitamin D supplementation and allergic conditions in adulthood: northern Finland birth cohort 1966. Ann N Y Acad Sci 1037: 84–95.

56.

James

Palmer

Kicic

Maxwell

Lagan

Ryan

. (2005) Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. Am J Respir Crit Care Med 171: 109–114.

57.

Joss-Moore

Albertine

Lane

(2011) Epigenetics and the developmental origins of lung disease. Mol Genet Metab 104: 61–66.

58.

Kallapur

Ikegami

(2006) Physiological consequences of intrauterine insults. Paediatr Respir Rev 7: 110–116.

59.

Karadag

Sakurai

Wang

Guo

Desai

Ross

. (2009) Effect of maternal food restriction on fetal rat lung lipid differentiation program. Pediatr Pulmonol 44: 635–644.

60.

Kohansal

Martinez-Camblor

Agusti

Buist

Mannino

Soriano

(2009) The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med 180: 3–10.

61.

Kotecha

Dunstan

Kotecha

(2012a) Long term respiratory outcomes of late preterm-born infants. Semin Fetal Neonatal Med 17: 77–81.

62.

Kotecha

Watkins

Heron

Henderson

Dunstan

Kotecha

(2010) Spirometric lung function in school-age children: effect of intrauterine growth retardation and catch-up growth. Am J Respir Crit Care Med 181: 969–974.

63.

Kotecha

Watkins

Paranjothy

Dunstan

Henderson

Kotecha

(2012b) Effect of late preterm birth on longitudinal lung spirometry in school age children and adolescents. Thorax 67: 54–61.

64.

Kramer

Kallapur

Newnham

Jobe

(2009) Prenatal inflammation and lung development. Semin Fetal Neonatal Med 14: 2–7.

65.

Kwinta

Pietrzyk

(2010) Preterm birth and respiratory disease in later life. Expert Rev Respir Med 4: 593–604.

66.

Lawlor

Ebrahim

Davey

(2005) Association of birth weight with adult lung function: findings from the British Women’s Heart and Health Study and a meta-analysis. Thorax 60: 851–858.

67.

Le Souef

(2000) Pediatric origins of adult lung diseases. 4. Tobacco related lung diseases begin in childhood. Thorax 55: 1063–1067.

68.

Le Souef

(2005) Can asthma be predicted from an early age? Curr Opin Allergy Clin Immunol 5: 71–75.

69.

Lopez

Mathers

Ezzati

Jamison

Murray

(2006) Measuring the Global Burden of Disease and Risk Factors, 1990–2001. Washington: World Bank.

70.

Lopuhaa

Roseboom

Osmond

Barker

Ravelli

Bleker

. (2000) Atopy, lung function, and obstructive airways disease after prenatal exposure to famine. Thorax 55: 555–561.

71.

Magnani

Cataneo

Capelozzi

Defaveri

Hasimoto

Cataneo

(2012) Lung morphology and growth of rats exposed to tobacco smoke and alcohol. Acta Cir Bras 27:687–693.

72.

Maritz

Mutemwa

(2012) Tobacco smoking: patterns, health consequences for adults, and the long-term health of the offspring. Glob J Health Sci 4: 62–75.

73.

Maritz

Mutemwa

Kayigire

(2011) Tomato juice protects the lungs of the offspring of female rats exposed to nicotine during gestation and lactation. Pediatr Pulmonol 46: 976–986.

74.

Maritz

Rayise

(2011) Effect of maternal nicotine exposure on neonatal rat lung development: protective effect of maternal ascorbic acid supplementation. Exp Lung Res 37: 57–65.

75.

Massaro

(2004) Critical period for alveologenesis and early determinants of adult pulmonary disease. Am J Physiol Lung Cell Mol Physiol 287: L715–L717.

76.

Mauad

Rivero

de Oliveira

Lichtenfels

Guimaraes

de Andre

. (2008) Chronic exposure to ambient levels of urban particles affects mouse lung development. Am J Respir Crit Care Med 178: 721–728.

77.

Miller

Marty

(2010) Impact of environmental chemicals on lung development. Environ Health Perspect 118: 1155–1164.

78.

Miyake

Sasaki

Tanaka

Hirota

(2010) Dairy food, calcium and vitamin D intake in pregnancy, and wheeze and eczema in infants. Eur Respir J 35: 1228–1234.

79.

Moore

Hennessy

Myles

Johnson

Draper

Costeloe

. (2012) Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies. BMJ 345: e7961.

80.

Morrisey

Hogan

(2010) Preparing for the first breath: genetic and cellular mechanisms in lung development. Dev Cell 18: 8–23.

81.

Moshammer

Hoek

Luttmann-Gibson

Neuberger

Antova

Gehring

. (2006) Parental smoking and lung function in children: an international study. Am J Respir Crit Care Med 173: 1255–1263.

82.

Murdzoska

Devadason

Khoo

Landau

Young

Goldblatt

. (2010) In utero smoke exposure and role of maternal and infant glutathione S-transferase genes on airway responsiveness and lung function in infancy. Am J Respir Crit Care Med 181: 64–71.

83.

Narang

Bush

(2012) Early origins of chronic obstructive pulmonary disease. Semin Fetal Neonatal Med 17: 112–118.

84.

Narayanan

Owers-Bradley

Beardsmore

Mada

Ball

Garipov

. (2012) Alveolarization continues during childhood and adolescence: new evidence from helium-3 magnetic resonance. Am J Respir Crit Care Med 185: 186–191.

85.

Neuman

Hohmann

Orsini

Pershagen

Eller

Kjaer

. (2012) Maternal smoking in pregnancy and asthma in preschool children: a pooled analysis of eight birth cohorts. Am J Respir Crit Care Med 186: 1037–1043.

86.

Ogbuanu

Karmaus

Arshad

Kurukulaaratchy

Ewart

(2009) Effect of breastfeeding duration on lung function at age 10 years: a prospective birth cohort study. Thorax 64: 62–66.

87.

O’Reilly

Marr

Yee

McGrath-Morrow

Lawrence

(2008) Neonatal hyperoxia enhances the inflammatory response in adult mice infected with influenza A virus. Am J Respir Crit Care Med 177: 1103–1110.

88.

Padhi

Padhy

(2008) Domestic fuels, indoor air pollution, and children’s health. Ann N Y Acad Sci 1140: 209–217.

89.

Palmer

Doney

Lee

Murrie

Ismail

Macgregor

. (2006) Glutathione S-transferase M1 and P1 genotype, passive smoking, and peak expiratory flow in asthma. Pediatrics 118: 710–716.

90.

Phelan

Robertson

Olinsky

(2002) The Melbourne Asthma Study: 1964–1999. J Allergy Clin Immunol 109: 189–194.

91.

Pike

Pillow

Lucas

(2012) Long term respiratory consequences of intrauterine growth restriction. Semin Fetal Neonatal Med 17: 92–98.

92.

Pike

Rose-Zerilli

Osvald

Inskip

Godfrey

Crozier

. (2011) The relationship between infant lung function and the risk of wheeze in the preschool years. Pediatr Pulmonol 46: 75–82.

93.

Postma

(2007) Gender differences in asthma development and progression. Gend Med 4(Suppl. B): S133–S146.

94.

Postma

Brusselle

Bush

Holloway

(2012) I have taken my umbrella, so of course it does not rain. Thorax 67: 88–89.

95.

Quanjer

Enright

Miller

Stocks

Ruppel

Swanney

. (2011) The need to change the method for defining mild airway obstruction. Eur Respir J 37: 720–722.

96.

Quanjer

Stanojevic

Cole

Baur

Hall

Culver

. (2012) Multi-ethnic reference values for spirometry for the 3–95 year age range: the global lung function 2012 equations. Eur Respir J 40: 1324–1343.

97.

Quanjer

Stanojevic

Stocks

Hall

Prasad

Cole

. (2010) Changes in the FEV(1)/FVC ratio during childhood and adolescence: an intercontinental study. Eur Respir J 36: 1391–1399.

98.

Rona

Smeeton

Bustos

Amigo

Diaz

(2005) The early origins hypothesis with an emphasis on growth rate in the first year of life and asthma: a prospective study in Chile. Thorax 60: 549–554.

99.

Salvi

Barnes

(2009) Chronic obstructive pulmonary disease in non-smokers. Lancet 374: 733–743.

100.

Sandberg

Pinkerton

Poole

Minton

Sundell

(2011) Fetal nicotine exposure increases airway responsiveness and alters airway wall composition in young lambs. Respir Physiol Neurobiol 176: 57–67.

101.

Schindler

Keidel

Gerbase

Zemp

Bettschart

Brandli

. (2009) Improvements in PM10 exposure and reduced rates of respiratory symptoms in a cohort of Swiss adults (SAPALDIA). Am J Respir Crit Care Med 179: 579–587.

102.

Schittny

Mund

Stampanoni

(2008) Evidence and structural mechanism for late lung alveolarization. Am J Physiol Lung Cell Mol Physiol 294: L246–L254.

103.

Schultz

Devadason

Khoo

Zhang

Bizzintino

Martin

. (2010) The role of GSTP1 polymorphisms and tobacco smoke exposure in children with acute asthma. J Asthma 47: 1049–1056.

104.

Schultz

Gruzieva

Bellander

Bottai

Hallberg

Kull

. (2012) Traffic-related air pollution and lung function in children at 8 years of age – a birth cohort study. Am J Respir Crit Care Med 186: 1286–1291.

105.

Sears

Greene

Willan

Wiecek

Taylor

Flannery

. (2003) A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. New Engl J Med 349: 1414–1422.

106.

Shimoda

Semenza

(2011) HIF and the lung: role of hypoxia-inducible factors in pulmonary development and disease. Am J Respir Crit Care Med 183: 152–156.

107.

Shirtcliffe

Marsh

Travers

Weatherall

Beasley

(2012) Childhood asthma and GOLD-defined chronic obstructive pulmonary disease. Intern Med J 42: 83–88.

108.

Silverman

Kuehni

(2007) Early lung development and COPD. Lancet 370: 717–719.

109.

Sin

Man

(2005) The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 127: 1952–1959.

110.

Soto-Martinez

Sly

(2010) Relationship between environmental exposures in children and adult lung disease: the case for outdoor exposures. Chron Respir Dis 7: 173–186.

111.

Soto-Ramirez

Alexander

Karmaus

Yousefi

Zhang

Kurukulaaratchy

. (2012) Breastfeeding is associated with increased lung function at 18 years of age: a cohort study. Eur Respir J 39: 985–991.

112.

Stern

Morgan

Wright

Guerra

Martinez

(2007) Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet 370: 758–764.

113.

Stocks

Dezateux

(2003) The effect of parental smoking on lung function and development during infancy. Respirology 8: 266–285.

114.

Stocks

Hislop

(2002) Structure and function of the respiratory system: developmental aspects and their relevance to aerosol therapy, In: Bisgaard

. (eds), Drug Delivery to the Lung: Clinical Aspects. New York: Marcel Dekker, Inc., pp. 47–104.

115.

Stocks

Lum

(2012) Pulmonary function tests in infants and preschool children, In: Wilmott

. (eds), Kendig’s Disorders of the Respiratory Tract in Children, 8th edition. Philadelphia, PA: Elsevier, pp. 169–210.

116.

Sutherland

Crossley

Allison

Jenkin

Wallace

Miller

(2012) The effects of intrauterine growth restriction and antenatal glucocorticoids on ovine fetal lung development. Pediatr Res 71: 689–696.

117.

Svanes

Omenaas

Jarvis

Chinn

Gulsvik

Burney

(2004) Parental smoking in childhood and adult obstructive lung disease: results from the European Community Respiratory Health Survey. Thorax 59: 295–302.

118.

Svanes

Sunyer

Plana

Dharmage

Heinrich

Jarvis

. (2010) Early life origins of chronic obstructive pulmonary disease. Thorax 65: 14–20.

119.

Tabak

Smit

Heederik

Ocke

Kromhout

(2001) Diet and chronic obstructive pulmonary disease: independent beneficial effects of fruits, whole grains, and alcohol (the MORGEN study). Clin Exp Allergy 31: 747–755.

120.

Tai

Tran

Roberts

Clarke

Wilson

Robertson

(2010) Pediatric origins of adult chronic obstructive pulmonary disease (COPD): childhood asthma. Am J Respir Crit Care Med 181: A2275.

121.

Thornburg

Shannon

Thuillier

Turker

(2010) In utero life and epigenetic predisposition for disease. Adv Genet 71: 57–78.

122.

Tiddens

Hofhuis

Casotti

Hop

Hulsmann

de Jongste

(2008) Airway dimensions in bronchopulmonary dysplasia: implications for airflow obstruction. Pediatr Pulmonol 43: 1206–1213.

123.

Tsai

Liu

Mestan

Zhang

Fang

. (2008) Maternal cigarette smoking, metabolic gene polymorphisms, and preterm delivery: new insights on G×E interactions and pathogenic pathways. Hum Genet 123: 359–369.

124.

Turner

Palmer

Rye

Gibson

Judge

Cox

. (2004) The relationship between infant airway function, childhood airway responsiveness, and asthma. Am J Respir Crit Care Med 169: 921–927.

125.

Turner

Prabhu

Danielan

McNeill

Craig

Allan

. (2011) First- and second-trimester fetal size and asthma outcomes at age 10 years. Am J Respir Crit Care Med 184: 407–413.

126.

Turner

Young

Landau

Le Souef

(2002) Reduced lung function both before bronchiolitis and at 11 years. Arch Dis Child 87: 417–420.

127.

Upton

Smith

McConnachie

Hart

Watt

. Maternal and personal cigarette smoking synergize to increase airflow limitation in adults. Am J Respir Crit Care Med 2004 169(4): 479–487.

128.

Velten

Heyob

Rogers

Welty

(2010) Deficits in lung alveolarization and function after systemic maternal inflammation and neonatal hyperoxia exposure. J Appl Physiol 108: 1347–1356.

129.

Vrijlandt

Gerritsen

Boezen

Duiverman

(2005) Gender differences in respiratory symptoms in 19-year-old adults born preterm. Respir Res 6: 117–124.

130.

Vrijlandt

Gerritsen

Boezen

Grevink

Duiverman

(2006) Lung function and exercise capacity in young adults born prematurely. Am J Respir Crit Care Med 173: 890–896.

131.

Wang

Salam

Islam

Wenten

Gauderman

Gilliland

(2008) Effects of in utero and childhood tobacco smoke exposure and beta2-adrenergic receptor genotype on childhood asthma and wheezing. Pediatrics 122: e107–e114.

132.

Weiss

Litonjua

(2011) The in utero effects of maternal vitamin D deficiency: how it results in asthma and other chronic diseases. Am J Respir Crit Care Med 183: 1286–1287.

133.

Wenten

Lin

Gauderman

Berhane

Avol

. (2009) In utero smoke exposure, glutathione S-transferase P1 haplotypes, and respiratory illness-related absence among schoolchildren. Pediatrics 123: 1344–1351.

134.

Wong

Lees

Louw

Lee

French

Gain

. (2008) Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia. Eur Respir J 32: 321–328.

135.

Wongtrakool

Wang

Hyde

Roman

Spindel

(2012) Prenatal nicotine exposure alters lung function and airway geometry through alpha7 nicotinic receptors. Am J Respir Cell Mol Biol 46: 695–702.

136.

WHO (2008) World Health Statistics. Geneva: World Health Organization.

137.

Young

Hopkins

Eaton

(2007) Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes. Eur Respir J 30: 616–622.

138.

Zosky

Berry

Elliot

James

Gorman

Hart

(2011) Vitamin D deficiency causes deficits in lung function and alters lung structure. Am J Respir Crit Care Med 183: 1336–1343.

Early life influences on the development of chronic obstructive pulmonary disease

Abstract

Keywords

Introduction

Normal lung development

Early life influences that may predispose to COPD

Prenatal risk factors for COPD

Maternal smoking during pregnancy

Low Birth Weight (LBW)

Postnatal risk factors for COPD

Chronic lung disease of prematurity

Postnatal growth and nutrition

Postnatal exposure to environmental tobacco smoke

Environmental pollution

Childhood respiratory illnesses

Summary

Conclusion

Footnotes

Funding

Conflict of interest statement

References